NEVRO
Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy. Senza, HF10, Nevro and the Nevro logo are trademarks of Nevro.
NEVRO
Industry:
Biotechnology Health Care Health Diagnostics Pharmaceutical
Founded:
2006-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.nevro.com
Total Employee:
501+
Status:
Active
Contact:
6504333206
Email Addresses:
[email protected]
Total Funding:
355.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Font Awesome Amazon IPv6
Similar Organizations
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
CRG
CRG investment in Debt Financing - Nevro
Accuitive Medical Ventures
Accuitive Medical Ventures investment in Series C - Nevro
MPM Capital
MPM Capital investment in Series C - Nevro
Novo Ventures
Novo Ventures investment in Series C - Nevro
Bay City Capital
Bay City Capital investment in Series C - Nevro
New Enterprise Associates
New Enterprise Associates investment in Series C - Nevro
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series C - Nevro
Mayo Clinic
Mayo Clinic investment in Series C - Nevro
Covidien Ventures
Covidien Ventures investment in Series C - Nevro
Three Arch Partners
Three Arch Partners investment in Series C - Nevro
Key Employee Changes
| Date | New article |
|---|---|
| 2020-06-04 | Nevro appoints Stryker veteran as CFO |
Official Site Inspections
http://www.nevro.com Semrush global rank: 290.68 K Semrush visits lastest month: 223.05 K
Unable to get host informations!!!
More informations about "Nevro"
Nevro Corp. - US - Relief, Multiplied
One comprehensive solution for individualized relief of chronic pain that gives you more versatility than ever before. The sum of excellence in four key areas to support you in providing your …See details»
Nevro Corp. - Leadership Team
Kevin Thornal was named CEO and President of Nevro in April of 2023. He will also be appointed to the Nevro Board of Directors. Mr. Thornal has over 20 years of senior management …See details»
Nevro Corp. - EN - Home
One comprehensive solution for individualized relief of chronic pain that gives you more versatility than ever before. The sum of excellence in four key areas to support you in providing your …See details»
Nevro - Crunchbase Company Profile & Funding
Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord …See details»
Nevro - LinkedIn
Nevro is a global medical device company focused on delivering innovation to improve the quality of life for patients suffering from debilitating chronic pain.See details»
Nevro considers sale as competition for pain market ramps up
Aug 8, 2024 · Nevro’s board hired Thornal in 2023 with a brief to address challenges in the SCS market. One of Thornal’s strategies is to buy other companies to expand beyond SCS. Last …See details»
Nevro Corp. (NVRO) Company Profile & Facts - Yahoo Finance
See the company profile for Nevro Corp. (NVRO) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
Environmental, Social and Governance Responsibilities at Nevro
Nevro is a medical device company headquartered in Redwood City, California that has the simple goal of helping more patients suffering from chronic pain achieve lastingSee details»
Nevro Company Profile - Office Locations, Competitors, Revenue …
Oct 28, 2024 · Nevro has 5 employees across 6 locations and $425.17 m in annual revenue in FY 2023. See insights on Nevro including office locations, competitors, revenue, financials, …See details»
Nevro Corp. - Investors
Headquartered in Redwood City, California, Nevro is a global medical device company focused on delivering comprehensive, life-changing solutions that continue to set the standard for enduring patient outcomes in chronic pain …See details»
Nevro's HFX iQâ„¢ Spinal Cord Stimulation with AI ... - Morningstar
Nov 12, 2024 · HFX iQ is the first and only spinal cord stimulation (SCS) system integrating high-frequency SCS landmark evidence with cloud data insights, leading the way for personalized, …See details»
Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 …
Jan 9, 2024 · Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced its …See details»
Nevro Corp (NVRO-N) Stock Price and News - The Globe and Mail
Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg.See details»
Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology …
REDWOOD CITY, Calif., Nov. 12, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the …See details»
Nevro Corp. - Nevro Announces Preliminary, Unaudited Fourth …
REDWOOD CITY, Calif., Jan. 10, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the …See details»
On Our Environmental, Social and Governance Responsibilities
We recognize the growing importance of ESG to our stakeholders: customers, patients, shareholders, employees, suppliers and communities. We are committed to operating our …See details»
Nevro Corp, NVRO:NYQ summary - FT.com - Financial Times
Oct 31, 2024 · Latest Nevro Corp (NVRO:NYQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.See details»
Nevro Corp. (NVRO) Stock Price, News, Quote & History - Yahoo …
Find the latest Nevro Corp. (NVRO) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Nevro Corp. - Nevro's HFX iQâ„¢ Spinal Cord Stimulation with AI ...
REDWOOD CITY, Calif., Nov. 12, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the …See details»
Nevro Corp. - Nevro Reports Second Quarter 2022 Financial …
REDWOOD CITY, Calif., Aug. 3, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its …See details»